Stocks · Health care · Services-Health Services

GeneDx Holdings Corp.

WGS Clue Score60
United States Fiscal year ends December CIK 0001818331 Results filed 3 Aug 2026

What the insiders did No buying or selling

By person

12 insiders · 0 transactions
15.9×

Katherine Stueland holds 15.9 times base salary in stock. $11.43M of shares against $715.87K in salary for 2025.

Salary from the company's own proxy. The shares are what Katherine Stueland last reported holding, valued at $99.00, the price Class A Common Stock was last bought or sold at on the open market here, on 16 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Keith A. Meister
Director
—
—
—
4,808,275
$476.00M
+93.8%
Casdin Capital, LLC entity
Director
—
—
—
3,707,164
$366.99M
+5.7%
School Of Medicine At Mount Sinai Icahn
10% owner
—
—
—
2,719,692
$269.24M
−5.1%
Joshua Ruch
Director
—
—
—
153,382
$15.18M
−7.6%
Jason Ryan
Director
—
—
—
118,764
$11.76M
−64.0%
Katherine Stueland
Chief Executive Officer
—
—
—
115,476
$11.43M
+9.5%
Richard C Pfenniger Jr
Director
—
—
—
45,082
$4.46M
+63.0%
Kevin Feeley
Chief Financial Officer
—
—
—
44,945
$4.45M
−50.0%
Emily M. Leproust
Director
—
—
—
24,852
$2.46M
+197.6%
Eli Casdin
Director
—
—
—
24,093
$2.39M
+217.3%
Thomas Fuchs
Director
—
—
—
1,146
$113.45K
—
Bryan Dechairo
Chief Operating Officer
—
—
—
0
$0.00
—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.